Net profit of Ajanta Pharma rose 56.14% to Rs 210.03 crore in the quarter ended December 2023 as against Rs 134.51 crore during the previous quarter ended December 2022. Sales rose 13.73% to Rs 1105.15 crore in the quarter ended December 2023 as against Rs 971.77 crore during the previous quarter ended December 2022.
Particulars | Quarter Ended |
| Dec. 2023 | Dec. 2022 | % Var. |
Sales | 1105.15 | 971.77 | 14 |
OPM % | 28.42 | 17.45 | - |
PBDT | 325.17 | 201.64 | 61 |
PBT | 290.91 | 168.34 | 73 |
NP | 210.03 | 134.51 | 56 |